A substantial number of women experience sleep difficulties in the approach to menopause
and beyond, with 26% experiencing severe symptoms that impact daytime functioning …

Introduction: Although international clinical practice guidelines recognize a continued role
for menopausal hormone therapy (HT), particularly for symptomatic women< 60 years of age …

Objective Review evidence to guide management of menopausal signs and symptoms in
women after breast cancer and make recommendations accordingly. Evidence Randomized …

Abstract Background Serotonin (5‐hydroxytryptamine) is a multifunctional bioamine serving
as a neurotransmitter, peripheral hormone and mitogen in the vertebrate system. It has …

Most individuals diagnosed with breast cancer will experience long-term survival. Following
initial active treatment for breast cancer, survivors may experience a variety of medical …

Opinion statement Around 90% of breast tumours are diagnosed in the early stage, with
approximately 70% being hormone receptor-positive. The cornerstone of adjuvant therapy …

Abstract Objective This Committee Opinion outlines the gynaecologic management
recommendations for women diagnosed with hereditary breast and ovarian cancer …

Introductions For young premenopausal breast cancer patients, adjuvant chemotherapy may
cause menstrual disruptions and premature menopause, which may in turn impair their …

Abstract Background The Midlife Women's Health Study (MWHS) was developed to address
some of the gaps in knowledge regarding risk factors for hot flashes among generally …

Breast cancer remains the most common cancer in women in the United States. For certain
women at high risk for breast cancer, endocrine therapy (ET) can greatly decrease the risk …